| Trial ID: | L6906 |
| Source ID: | NCT00480805
|
| Associated Drug: |
Mk0954a, Losartan Potassium (+) Hydrochlorothiazide (Hyzaar) / Duration Of Treatment : 8 Weeks
|
| Title: |
HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Hypertension
|
| Interventions: |
DRUG: MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks|DRUG: Comparator : ramipril /Duration of Treatment : 8 Weeks
|
| Outcome Measures: |
Primary: To determine the antihypertensive effectiveness of HYZAAR as compared to Ramipril as measure by SiSBP at Week 4 | Secondary: To determine the safety anf tolerability of HYZAAR as compared to Ramipril as seen in overall adverse experiences for the duration of the study
|
| Sponsor/Collaborators: |
Sponsor: Organon and Co
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
312
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-08-08
|
| Completion Date: |
2002-10-16
|
| Results First Posted: |
|
| Last Update Posted: |
2024-08-15
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00480805
|
